Helen Katrina Tayton-martin, Chief Business Officer at Adaptimmune Therapeutics PLC (ADAP), sold 100,000 shares at $4.00 ($450K) on 2020-01-13, disclosed to the SEC on 2020-01-15.
Open-market sale of $450k ADAP by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.00 | 50,000 | $200K | 44.4% |
| 2 | $5.00 | 50,000 | $250K | 55.6% |
| Total | $4.50 avg | 100,000 | $450K | 100% |